cannabis indica

Índice completo — página 57 de 77

Estudos 5.601 a 5.700 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2015. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 5.601 a 5.700

  1. 2015

    Geraniol attenuates fibrosis and exerts anti-inflammatory effects on diet induced atherogenesis by NF-κB signaling pathway.

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Aterosclerose
  2. 2015

    Geraniol Suppresses Angiogenesis by Downregulating Vascular Endothelial Growth Factor (VEGF)/VEGFR-2 Signaling

    FavorávelEstudo em AnimaisCâncer
  3. 2015

    High-intensity Cannabis Use Associated With Lower Plasma Human Immunodeficiency virus-1 RNA Viral Load Among Recently Infected People Who Use Injection Drugs

    FavorávelMetanáliseHIV/AIDS
  4. 2015

    Homer Protein-Metabotropic Glutamate Receptor Binding Regulates Endocannabinoid Signaling and Affects Hyperexcitability in a Mouse Model of Fragile X Syndrome

    FavorávelEstudo em AnimaisSíndrome do X Frágil
  5. 2015

    HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid

    FavorávelEstudo em AnimaisInflamaçãoArtriteArtrite — ReumatoideCanabinoides Sintéticos HU-x+1
  6. 2015

    Hypothalamic POMC neurons promote cannabinoid-induced feeding

    FavorávelEstudo em AnimaisAnorexia (perda de apetite)CaquexiaAnorexia Nervosa
  7. 2015

    Identification of CB₂ receptors in human nigral neurons that degenerate in Parkinson's disease.

    FavorávelEstudo LaboratorialDoença de Parkinson
  8. 2015

    Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDorCâncerInsônia e Distúrbios do SonoTHC Farmacêutico+6
  9. 2015

    In Vitro Antimalarial Activity of Different Inhibitors of the Plasmodial Isoprenoid Synthesis Pathway

    FavorávelEstudo LaboratorialMalária
  10. 2015

    Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells.

    FavorávelEstudo LaboratorialCâncerCâncer — Cérebro
  11. 2015

    Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress

  12. 2015

    Intraperirhinal cortex administration of the synthetic cannabinoid, HU210, disrupts object recognition memory in rats

  13. 2015

    Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisNáusea e VômitoTetraidrocanabinol (THC)
  14. 2015

    Invited Commentary: The Association Between Marijuana Use and Male Reproductive Health

    DesfavorávelMetanáliseInfertilidade Masculina
  15. 2015

    Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety

  16. 2015

    K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.

  17. 2015

    Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death

    DesfavorávelMetanáliseAyahuasca
  18. 2015

    Linalool inhibits cigarette smoke-induced lung inflammation by inhibiting NF-κB activation.

    FavorávelEstudo em AnimaisDorInflamaçãoDependência — Nicotina+1
  19. 2015

    Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes

    InconclusivoMetanáliseEfeitos Adversos da CannabisGestação
  20. 2015

    Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility

    DesfavorávelMetanáliseInfertilidade Masculina
  21. 2015

    Marijuana's acute effects on cognitive bias for affective and marijuana cues

  22. 2015

    MDMA, cannabis, and cocaine produce acute dissociative symptoms

    DesfavorávelEnsaio ClínicoDependência QuímicaEfeitos Adversos da CannabisAnsiedade+8
  23. 2015

    Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review

    FavorávelMetanálise ClínicaDorDor — CrônicaEsclerose Múltipla+1
  24. 2015

    Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting.

    FavorávelMetanáliseNáusea e VômitoNáusea e Vômito por Quimioterapia
  25. 2015

    Mismatch negativity in tobacco-naïve cannabis users and its alteration with acute nicotine administration

  26. 2015

    Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol.

    FavorávelEstudo em AnimaisHIV/AIDS
  27. 2015

    Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway; novel anti-tumor mechanisms of Cannabidiol in breast cancer

    FavorávelEstudo em AnimaisCâncerCâncer — Mama
  28. 2015

    Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells

    FavorávelEstudo LaboratorialCâncerCâncer — MamaFicocianina
  29. 2015

    Monoacylglycerol Lipase Regulates Fever Response

    FavorávelEstudo em AnimaisEpilepsiaEpilepsia — FIRESMonoacilglicerol Lipase (MAGL)
  30. 2015

    Motivational interviewing and interaction skills training for parents of young adults with recent-onset schizophrenia and co-occurring cannabis use: 15-month follow-up

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisPsicose+1
  31. 2015

    Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  32. 2015

    Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers

    FavorávelEnsaio Clínico Duplo-CegoObesidadePerda de ApetiteTetraidrocanabivarina (THCV)
  33. 2015

    Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis

  34. 2015

    Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice

    FavorávelEstudo em AnimaisDoença de HuntingtonCanabigerol (CBG)
  35. 2015

    Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications

  36. 2015

    New horizons for newborn brain protection: enhancing endogenous neuroprotection

  37. 2015

    No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper

  38. 2015

    Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity

    FavorávelEstudo em AnimaisAVC2-Araquidonoilglicerol (2-AG)
  39. 2015

    Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects

    DesfavorávelEnsaio ClínicoNáusea e VômitoAnandamida (AEA)Endocanabinoide (não especificado)+1
  40. 2015

    On The Effects Of CP 55-940 And Other Cannabinoid Receptor Agonists In C6 And U373 Cell Lines

    FavorávelEstudo LaboratorialCâncerCâncer — CérebroAnandamida (AEA)Canabinoides Sintéticos WIN-x+1
  41. 2015

    Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury

  42. 2015

    Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors

    FavorávelEstudo em AnimaisEpilepsiaCanabinoides Sintéticos AM-xPalmitoiletanolamida (PEA)
  43. 2015

    Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals

  44. 2015

    Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats

    FavorávelEstudo em AnimaisDorInflamaçãoDiabetesPalmitoiletanolamida (PEA)+2
  45. 2015

    Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome

  46. 2015

    Perceived Efficacy Of Cannabidiol-enriched Cannabis Extracts For Treatment Of Pediatric Epilepsy: A Potential Role For Infantile Spasms And Lennox-Gastaut Syndrome (LGS).

    FavorávelMetanáliseEpilepsiaEpilepsia — Lennox-Gastaut
  47. 2015

    Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA

  48. 2015

    Physicochemical characterization and analgesic effect of inclusion complexes of essential oil from Hyptis pectinata L. Poit leaves with β-cyclodextrin.

  49. 2015

    Phytol in a Pharma-Medico-Stance

    FavorávelMetanáliseCâncerDoenças Cardiovasculares (DCV)Diabetes+1
  50. 2015

    Phytol Induces Apoptosis and ROS-Mediated Protective Autophagy in Human Gastric Adenocarcinoma AGS Cells

    FavorávelEstudo LaboratorialCâncerCâncer — MamaCâncer — Pulmão+2
  51. 2015

    Possible opioid-saving effect of cannabis-based medicine using individual-based data from the Norwegian Prescription Database

  52. 2015

    Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.

    FavorávelMetanáliseCâncerCâncer — Cérebro
  53. 2015

    Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol.

    FavorávelEstudo em AnimaisObesidadeDesequilíbrio do Microbioma
  54. 2015

    Proapoptotic effect of endocannabinoids in prostate cancer cells

    FavorávelEstudo LaboratorialCâncerCâncer — PróstataAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  55. 2015

    Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection

  56. 2015

    Protective Role of Cannabinoid Receptor 2 Activation in Galactosamine/Lipopolysaccharide-Induced Acute Liver Failure through Regulation of Macrophage Polarization and MicroRNAs

    FavorávelEstudo em AnimaisInsuficiência HepáticaCanabinoides Sintéticos JWH-x
  57. 2015

    Psychedelic symptoms of cannabis and cocaine use as a function of trait impulsivity

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisAnsiedadeDepressão+2
  58. 2015

    Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus

  59. 2015

    Regulation of inflammation and proliferation of human bladder carcinoma cells by type-1 and type-2 cannabinoid receptors

  60. 2015

    Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial

  61. 2015

    Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans

    FavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDisfunção Cognitiva
  62. 2015

    Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease

  63. 2015

    Safety And Pharmacokinetics Of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl In Humans

    FavorávelEnsaio ClínicoDorDependência QuímicaDor — Crônica+1
  64. 2015

    Safety of oral dronabinol during opioid withdrawal in humans

  65. 2015

    Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia

  66. 2015

    Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis

    FavorávelEnsaio Clínico Duplo-CegoEsclerose MúltiplaTHC:CBD Farmacêutico
  67. 2015

    Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults

    FavorávelEnsaio ClínicoVerminosesProteína Ligadora de Ácidos Graxos (FABP)
  68. 2015

    Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome

    FavorávelEstudo LaboratorialSíndrome dos Ovários Policísticos
  69. 2015

    Selected Compounds Structurally Related to Acyclic Sesquiterpenoids and Their Antibacterial and Cytotoxic Activity

    FavorávelEstudo LaboratorialCâncerInfecções BacterianasCâncer — Pulmão+3
  70. 2015

    Selective, nontoxic CB(2) cannabinoid o-quinone with in vivo activity against triple-negative breast cancer.

    FavorávelEstudo em AnimaisCâncerCâncer — Mama
  71. 2015

    Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability

  72. 2015

    Substance Use in Patients With First-Episode Psychosis: Is Gender Relevant?

  73. 2015

    Synergistic Antitumor Effect of α-Pinene and β-Pinene With Paclitaxel Against Non-Small-Cell Lung Carcinoma (NSCLC)

    FavorávelEstudo LaboratorialCâncerCâncer — Pulmão
  74. 2015

    Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases

  75. 2015

    Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption

    FavorávelEstudo LaboratorialCâncer — Mieloma
  76. 2015

    Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoDisfunção CognitivaTHC Farmacêutico+4
  77. 2015

    Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDoença de AlzheimerTranstornos de ComportamentoDemênciaTetraidrocanabinol (THC)
  78. 2015

    The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects

  79. 2015

    The Anticancer, Antioxidant And Antimicrobial Properties Of The Sesquiterpene β-Caryophyllene From The Essential Oil Of Aquilaria Crassna

    FavorávelEstudo LaboratorialCâncerEstresse OxidativoCâncer — Cólon+1
  80. 2015

    The Antitumor Action Of Cannabinoids On Glioma Tumorigenesis

  81. 2015

    The association between impulsivity and alcohol/drug use among prison inmates

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Opioides+6
  82. 2015

    The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts.

    FavorávelEstudo em AnimaisRejeição de Transplante
  83. 2015

    The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis

  84. 2015

    The dark side of emotion: the addiction perspective

  85. 2015

    The effect of acute alcohol intoxication on gut wall integrity in healthy male volunteers; a randomized controlled trial

  86. 2015

    The Effect of Phytocannabinoids on Airway Hyper-Responsiveness, Airway Inflammation, and Cough.

    FavorávelEstudo em AnimaisTosseTetraidrocanabinol (THC)Canabinoides Sintéticos AM-x+5
  87. 2015

    The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review

    InconclusivoMetanálise ClínicaDorDor — CrônicaDor — Neuropatia Periférica
  88. 2015

    The Effects Of Dronabinol During Detoxification And The Initiation Of Treatment With Extended Release Naltrexone.

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — OpioidesTHC Farmacêutico
  89. 2015

    The Effects of Lithium Carbonate Supplemented with Nitrazepam on Sleep Disturbance during Cannabis Abstinence

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  90. 2015

    The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study

    InconclusivoMetanáliseDPOCBronquite
  91. 2015

    The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.

    FavorávelEnsaio Clínico Duplo-CegoTEPT
  92. 2015

    The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.

  93. 2015

    The endocannabinoid system and its therapeutic implications in rheumatoid arthritis

    FavorávelMetanáliseArtriteArtrite — Reumatoide
  94. 2015

    The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [11C]CURB

  95. 2015

    The neuroprotection of cannabidiol against MPP(+)-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease.

    FavorávelEstudo LaboratorialEstresse OxidativoDoenças NeurodegenerativasDoença de Parkinson+1
  96. 2015

    The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects

    FavorávelEstudo em AnimaisPsicoseEsquizofreniaTetraidrocanabivarina (THCV)
  97. 2015

    The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisPsicoseTetraidrocanabinol (THC)
  98. 2015

    The rapidly increasing trend of cannabis use in burn injury

    InconclusivoMetanáliseQueimaduras
  99. 2015

    The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content

    FavorávelEnsaio Clínico Duplo-CegoInflamaçãoDoenças de PeleAcne+1
  100. 2015

    The therapeutic potential of cannabinoids for movement disorders

    FavorávelMetanáliseDoença de ParkinsonDoença de HuntingtonDistonia+1